Eintrag weiter verarbeiten
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Gespeichert in:
Zeitschriftentitel: | OncoTargets and Therapy |
---|---|
Personen und Körperschaften: | , , , , |
In: | OncoTargets and Therapy, Volume 10, 2017, S. 3363-3372 |
Medientyp: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Informa UK Limited
|
Schlagwörter: |
author_facet |
Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo |
---|---|
author |
Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo |
spellingShingle |
Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo OncoTargets and Therapy Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib Pharmacology (medical) Oncology |
author_sort |
kourie, hampig raphael |
spelling |
Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s122397 Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib OncoTargets and Therapy |
doi_str_mv |
10.2147/ott.s122397 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
Informa UK Limited, 2017 |
imprint_str_mv |
Informa UK Limited, 2017 |
issn |
1178-6930 |
issn_str_mv |
1178-6930 |
language |
English |
mega_collection |
Informa UK Limited (CrossRef) |
match_str |
kourie2017emergingtreatmentsforher2positiveearlystagebreastcancerfocusonneratinib |
publishDateSort |
2017 |
publisher |
Informa UK Limited |
recordtype |
ai |
record_format |
ai |
series |
OncoTargets and Therapy |
source_id |
49 |
title |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_unstemmed |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_full |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_fullStr |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_full_unstemmed |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_short |
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_sort |
emerging treatments for her2-positive early-stage breast cancer: focus on neratinib |
topic |
Pharmacology (medical) Oncology |
url |
http://dx.doi.org/10.2147/ott.s122397 |
publishDate |
2017 |
physical |
3363-3372 |
description |
|
container_start_page |
3363 |
container_title |
OncoTargets and Therapy |
container_volume |
Volume 10 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792339869788274688 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:54:59.568Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Emerging+treatments+for+HER2-positive+early-stage+breast+cancer%3A+focus+on+neratinib&rft.date=2017-07-01&genre=article&issn=1178-6930&volume=Volume+10&spage=3363&epage=3372&pages=3363-3372&jtitle=OncoTargets+and+Therapy&atitle=Emerging+treatments+for+HER2-positive+early-stage+breast+cancer%3A+focus+on+neratinib&aulast=Lambertini&aufirst=Matteo&rft_id=info%3Adoi%2F10.2147%2Fott.s122397&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792339869788274688 |
author | Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo |
author_facet | Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo, Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo |
author_sort | kourie, hampig raphael |
container_start_page | 3363 |
container_title | OncoTargets and Therapy |
container_volume | Volume 10 |
description | |
doi_str_mv | 10.2147/ott.s122397 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw |
imprint | Informa UK Limited, 2017 |
imprint_str_mv | Informa UK Limited, 2017 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 1178-6930 |
issn_str_mv | 1178-6930 |
language | English |
last_indexed | 2024-03-01T15:54:59.568Z |
match_str | kourie2017emergingtreatmentsforher2positiveearlystagebreastcancerfocusonneratinib |
mega_collection | Informa UK Limited (CrossRef) |
physical | 3363-3372 |
publishDate | 2017 |
publishDateSort | 2017 |
publisher | Informa UK Limited |
record_format | ai |
recordtype | ai |
series | OncoTargets and Therapy |
source_id | 49 |
spelling | Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s122397 Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib OncoTargets and Therapy |
spellingShingle | Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo, OncoTargets and Therapy, Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib, Pharmacology (medical), Oncology |
title | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_full | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_fullStr | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_full_unstemmed | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_short | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
title_sort | emerging treatments for her2-positive early-stage breast cancer: focus on neratinib |
title_unstemmed | Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib |
topic | Pharmacology (medical), Oncology |
url | http://dx.doi.org/10.2147/ott.s122397 |